280
Views
19
CrossRef citations to date
0
Altmetric
Research Article

Protective effects of sesamin on liver fibrosis through antioxidative and anti-inflammatory activities in rats

, , , &
Pages 465-472 | Received 18 Mar 2015, Accepted 03 Aug 2015, Published online: 14 Oct 2015

References

  • Iredale J. Defining therapeutic targets for liver fibrosis: exploiting the biology of inflammation and repair. Pharmacol Res 2008;58:129–136
  • Ghatak S, Biswas A, Dhali GK, et al. Oxidative stress and hepatic stellate cell activation are key events in arsenic induced liver fibrosis in mice. Toxicol Appl Pharmacol 2011;251:59–69
  • Bai T, Yao YL, Jin XJ, et al. Acanthoic acid, a diterpene in Acanthopanax koreanum, ameliorates the development of liver fibrosis via LXRs signals. Chem Biol Interact 2014;218:63–70
  • Shin DS, Kim KW, Chung HY, et al. Effect of sinapic acid against carbon tetrachloride-induced acute hepatic injury in rats. Arch Pharm Res 2013;36:626–633
  • Li R, Xu L, Liang T, Li Y, et al. Puerarin mediates hepatoprotection against CCl4-induced hepatic fibrosis rats through attenuation of inflammation response and amelioration of metabolic function. Food Chem Toxicol 2013;52:69–75
  • Jeng KC, Hou RC, Wang JC, Ping LI. Sesamin inhibits lipopolysaccharide-induced cytokine production by suppression of p38 mitogen-activated protein kinase and nuclear factor-kappaB. Immunol Lett 2005;97:101–106
  • Liu CM, Zheng GH, Ming QL, et al. Sesamin protects mouse liver against nickel-induced oxidative DNA damage and apoptosis by the PI3K-Akt pathway. J Agric Food Chem 2013;61:1146–1154
  • Bournival J, Francoeur MA, Renaud J, Martinoli MG. Quercetin and sesamin protect neuronal PC12 cells from high-glucose-induced oxidation, nitrosative stress, and apoptosis. Rejuvenation Res 2012;15:322–333
  • Lee CC, Liu KJ, Wu YC, et al. Sesamin inhibits macrophage-induced vascular endothelial growth factor and matrix metalloproteinase-9 expression and proangiogenic activity in breast cancer cells. Inflammation 2011;34:209–221
  • Wu XQ, Kong X, Zhou Y, et al. Sesamin exerts renoprotective effects by enhancing NO bioactivity in renovascular hypertensive rats fed with high-fat-sucrose diet. Eur J Pharmacol 2012;683:231–237
  • Penalvo JL, Hopia A, Adlercreutz H. Effect of sesamin on serum cholesterol and triglycerides levels in LDL receptor-deficient mice. Eur J Nutr 2006;45:439–444
  • Chang CY, Chen YL, Yang SC, et al. Effect of schisandrin B and sesamin mixture on CCl(4)-induced hepatic oxidative stress in rats. Phytother Res 2009;23:251–256
  • Ma JQ, Ding J, Zhang L, Liu CM. Hepatoprotective properties of sesamin against CCl4 induced oxidative stress-mediated apoptosis in mice via JNK pathway. Food Chem Toxicol 2014;64:41–48
  • Hou RC, Chen HL, Tzen JT, Jeng KC. Effect of sesame antioxidants on LPS-induced NO production by BV2 microglial cells. Neuroreport 2003;14:1815–1819
  • Phitak T, Pothacharoen P, Settakorn J, et al. Chondroprotective and anti-inflammatory effects of sesamin. Phytochemistry 2012;80:77–88
  • Friedman SL. Molecular regulation of hepatic fibrosis, an integrated cellular response to tissue injury. J Biol Chem 2000;275:2247–2250
  • Gressner AM. The cell biology of liver fibrogenesis – an imbalance of proliferation, growth arrest and apoptosis of myofibroblasts. Cell Tissue Res 1998;292:447–452
  • Chen X, Ying X, Zhang W, et al. The hepatoprotective effect of fraxetin on carbon tetrachloride induced hepatic fibrosis by antioxidative activities in rats. Int Immunopharmacol 2013;17:543–547
  • Ahmed AF, Mahmoud MF, Ouf MA, El-Fathaah EA. Aminoguanidine potentiates the hepatoprotective effect of silymarin in CCl4 treated rats. Ann Hepatol 2011;10:207–215
  • Jia R, Cao L, Du J, et al. The protective effect of silymarin on the carbon tetrachloride (CCl4)-induced liver injury in common carp (Cyprinus carpio). In Vitro Cell Dev Biol Anim 2013;49:155–161
  • Tsai CF, Hsu YW, Ting HC, et al. The in vivo antioxidant and antifibrotic properties of green tea (Camellia sinensis, Theaceae). Food Chem 2013;136:1337–1344
  • Yadav NP, Pal A, Shanker K, et al. Synergistic effect of silymarin and standardized extract of Phyllanthus amarus against CCl4-induced hepatotoxicity in Rattus norvegicus. Phytomedicine 2008;15:1053–1061
  • Kakkar P, Das B, Viswanathan PN. A modified spectrophotometric assay of superoxide dismutase. Indian J Biochem Biophys 1984;21:130–132
  • Lowry OH, Rosebrough NJ, Farr AL, et al. Protein measurement with the Folin phenol reagent. J Biol Chem 1951;193:265–275
  • Jamall IS, Finelli VN, Que Hee SS. A simple method to determine nanogram levels of 4-hydroxyproline in biological tissues. Anal Biochem 1981;112:70–75
  • Periasamy S, Hsu DZ, Chang PC, Liu MY. Sesame oil attenuates nutritional fibrosing steatohepatitis by modulating matrix metalloproteinases-2, 9 and PPAR-gamma. J Nutr Biochem 2014;25:337–344
  • Leong PK, Chiu PY, Chen N, et al. Schisandrin B elicits a glutathione antioxidant response and protects against apoptosis via the redox-sensitive ERK/Nrf2 pathway in AML12 hepatocytes. Free Radic Res 2011;45:483–495
  • Reiter RJ, Tan DX, Osuna C, et al. Actions of melatonin in the reduction of oxidative stress. A review. J Biomed Sci 2000;7:444–458
  • Naik SR, Panda VS. Antioxidant and hepatoprotective effects of Ginkgo biloba phytosomes in carbon tetrachloride-induced liver injury in rodents. Liver Int 2007;27:393–399
  • Yang YS, Ahn TH, Lee JC, et al. Protective effects of Pycnogenol on carbon tetrachloride-induced hepatotoxicity in Sprague–Dawley rats. Food Chem Toxicol 2008;46:380–387
  • Shim JY, Kim MH, Kim HD, et al. Protective action of the immunomodulator ginsan against carbon tetrachloride-induced liver injury via control of oxidative stress and the inflammatory response. Toxicol Appl Pharmacol 2010;242:318–325
  • Weber LW, Boll M, Stampfl A. Hepatotoxicity and mechanism of action of haloalkanes: carbon tetrachloride as a toxicological model. Crit Rev Toxicol 2003;33:105–136
  • Wang JQ, Chen X, Zhang C, et al. Phenylbutyric acid protects against carbon tetrachloride-induced hepatic fibrogenesis in mice. Toxicol Appl Pharmacol 2013;266:307–316
  • Bondini S, Kleiner DE, Goodman ZD, et al. Pathologic assessment of non-alcoholic fatty liver disease. Clin Liver Dis 2007;11:17–23

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.